GoodRx (GDRX) – Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of GoodRx (NASDAQ: GDRX) recently:

• 8/20/2026 – GoodRx had its price target raised by Barclays PLC from $3.00 to $4.00. They now have an “underweight” rating on the stock.
• 8/15/2026 – GoodRx was upgraded by Wall Street Zen from “hold” to “buy”.
• 8/13/2026 – GoodRx had its price target raised by UBS Group AG from $2.50 to $3.75. They now have a “neutral” rating on the stock.
• 8/11/2026 – GoodRx had its price target raised by TD Cowen from $4.00 to $5.00. They now have a “buy” rating on the stock.
• 8/11/2026 – GoodRx had its price target raised by Citigroup Inc. from $4.00 to $5.00. They now have a “buy” rating on the stock.
• 8/7/2026 – GoodRx was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
• 8/7/2026 – GoodRx had its “neutral” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $4.00 price target on the stock.
• 8/7/2026 – GoodRx had its price target raised by Wells Fargo & Company from $3.50 to $5.00. They now have an “overweight” rating on the stock.
• 8/6/2026 – GoodRx was given a new $5.00 price target by Leerink Partners.
• 7/23/2026 – GoodRx was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
• 7/23/2026 – GoodRx had its “buy” rating reaffirmed by Citigroup Inc..
• 7/8/2026 – GoodRx was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.

Insider Activity

In related news, major shareholder Francisco Partners Iv, L.P. sold 1,296,177 shares of GoodRx stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $3.50, for a total transaction of $4,536,619.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In the last three months, insiders have sold 2,760,995 shares of company stock valued at $9,673,207. 5.87% of the stock is currently owned by company insiders.

GoodRx Holdings, Inc (NASDAQ: GDRX) operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications. The platform also features price transparency tools that inform patients about cost variations and available discounts to alleviate the financial burden of prescription medications.

In addition to its core drug pricing service, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual consultations for a range of non-emergency conditions and prescription needs.